Publication | Closed Access

Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects

VaccinationVaccine SafetyPreventive MedicineVaccine ResearchHealth EconomicsHerd Immunity EffectsVaccine EfficacyInfection ControlPublic HealthMedicineHigh-risk PopulationEpidemiology